Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:00 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | TANG CAPITAL MANAGEMENT LLC | 294,626 2.300% | 294,626 (New Position) | View |
| 2024-11-14 10:11 am Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3,062,690 9.200% | 3,062,690 (New Position) | View |
| 2024-10-28 4:03 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Octagon Capital Advisors LP | 225,000 1.800% | 225,000 (New Position) | View |
| 2024-10-23 4:15 pm Sale | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Deep Track Capital LP | 660,136 5.220% | -24,020 (-3.51%) | View |
| 2024-10-16 4:30 pm Sale | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Cormorant Asset Management LP | 1,837,739 14.520% | -57,978 (-3.06%) | View |
| 2024-10-11 5:24 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | CITADEL ADVISORS LLC | 1,271,371 9.900% | 1,271,371 (New Position) | View |
| 2024-10-11 4:22 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Cormorant Asset Management LP | 1,895,717 14.980% | 1,895,717 (New Position) | View |
| 2024-10-11 4:15 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Samsara BioCapital L.P. | 824,155 6.500% | 824,155 (New Position) | View |
| 2024-10-11 4:00 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Deep Track Capital LP | 684,156 5.410% | 684,156 (New Position) | View |
| 2024-10-10 6:57 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | PERCEPTIVE ADVISORS LLC | 1,004,439 7.900% | 1,004,439 (New Position) | View |
| 2024-10-10 4:30 pm Purchase | 13D | ONKURE THERAPEUTICS, INC. CLAS OKUR | Carlyle Group Inc. CG | 273,045 2.200% | 273,045 (New Position) | View |
| 2024-10-09 4:01 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | ACORN BIOVENTURES L.P. | 1,439,674 11.400% | 1,439,674 (New Position) | View |
| 2024-10-09 11:40 am Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | BML Investment Partners L.P. | 447,815 3.500% | 447,815 (New Position) | View |
| 2024-10-08 7:34 pm Sale | 13D | ONKURE THERAPEUTICS, INC. CLAS OKUR | New Enterprise Associates 15 L.P. | 0 0.000% | -4,785,494 (Position Closed) | View |
| 2024-09-26 4:00 pm Sale | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | TANG CAPITAL PARTNERS LP | 2,946,260 8.800% | -383,740 (-11.52%) | View |
| 2024-05-21 10:12 am Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | BML Investment Partners L.P. | 3,692,963 11.000% | 1,998,734 (+117.97%) | View |
| 2024-05-08 4:33 pm Unchanged | 13D | ONKURE THERAPEUTICS, INC. CLAS OKUR | New Enterprise Associates 15 L.P. | 4,785,494 14.300% | 0 (Unchanged) | View |
| 2024-02-05 4:01 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Octagon Capital Advisors LP | 2,250,000 6.750% | 2,250,000 (New Position) | View |
| 2024-01-16 5:54 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | BML Investment Partners L.P. | 1,694,229 5.100% | 1,694,229 (New Position) | View |
| 2023-12-26 5:00 pm Purchase | 13D | ONKURE THERAPEUTICS, INC. CLAS OKUR | TANG CAPITAL PARTNERS LP | 3,330,000 9.996% | 3,330,000 (New Position) | View |